Hahn's Priorities For US FDA Eschew Hot-Button Issues, Focus on Traditional Themes

 
• By Derrick Gingery
Commissioner Stephen Hahn addresses FDA staff for the first time on 30 January 2020; his accompanying all-hands memo did not mention controversial issues like drug pricing or opioids. • Source: FDA

More from US FDA

More from Agency Leadership